KLK3 and neoplasm: Progensa prostate cancer antigen 3 (PCA3) is a prognostic marker that measures the ratio of PCA3 to PSA (KLK3) mRNA and was found to be significantly higher in patients with mpMRI-visible tumours [7], [8].